Thursday, May 25, 2017

Kootenay Zinc Corp. (CSE: ZNK) (OTCQB: KTNNF) to Step Up Exploration Efforts following Chinese Production Cuts

Zinc prices soared over the last few days after top consumer China increased imports of the metal in wake of the country’s halting production as part of an environmental crackdown on the local steel industry. The Asian nation’s move to curb zinc and nickel production is likely to have a significant impact on global supply, with inventories already under pressure from growing demand and currently at about 342,675 tons (roughly 20 percent lower than last year), according to Reuters (http://dtn.fm/gP0yM). Zinc exploration corporations such as Vancouver-based Kootenay Zinc Corp. (CSE: ZNK) (OTCQB: KTNNF) are already exploring ways to step up efforts to find deposits so as to help meet the global demand for zinc.

Refined zinc imports to China jumped 21 percent year-over-year last month, reaching 47,469 tons (http://dtn.fm/H9mbb). Similarly, shipments of zinc ore and concentrates increased by 44 percent, Reuters said. This led to a significant increase in zinc prices, with the London Metal Exchange benchmark zinc closing up one percent at $2,658 per ton earlier this week – the highest since the beginning of the month.

Nickel prices also soared to $9,395, the highest in three weeks, as a result of growing Chinese imports. The halt in Chinese nickel production is unlikely to have a major impact, since the country accounts for only four percent of global supply. The situation, however, is significantly different when it comes to zinc, as the Asian nation accounted for at least 38 percent of global production before the crackdown. Both nickel and zinc are used in the steel manufacturing process – zinc for galvanized steel and nickel for stainless steel.

It is yet unclear how much of the country’s zinc and nickel production will be affected by the crackdown, but industry sources say the government is shutting down all steel mills that emit excessive pollution, along with zinc and nickel mining operations. Several of these operations might be reopened if they are found in compliance with environmental regulations, the sources added.

China’s move is likely to drive zinc demand even higher. According to the International Lead and Zinc Study Group, demand for the metal is already exceeding supply, and the difference is expected to reach 226,000 tons this year (http://dtn.fm/Lb7BC).

To help meet the rising demand, Canada’s Kootenay Zinc Corp. has already taken steps to expand its exploration program at its Sully property in British Columbia. The property is located near the legendary Sullivan Mine, which was one of the world’s largest reserves of zinc, with an output of over 17 million tons of zinc and lead until it was closed down in 2001. Kootenay’s Sully Project is located 18 miles from Sullivan, and both properties share different environments of the same basin.

For more information, visit the company’s website at www.KootenayZinc.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Monaker Group, Inc. (MKGI) Announces Launch of NextTrip Website and Mobile App

Travel and technology company Monaker Group, Inc. (OTCQB: MKGI) this morning announced the launch of NextTrip, a new travel website and companion mobile app featuring instant alternative lodging rentals (ALRs). The NextTrip mobile app is now available for download on both Android and iOS devices, giving users access to more than 1.2 million instantly-bookable ALR properties, 200,000 hotels, 400 airlines, all major car rental companies and 10,000 tourist activities. “The launch of NextTrip demonstrates how Monaker has solved one of the biggest pain-points in the travel industry — lack of access to instant booking of ALR,” Bill Kerby, CEO of Monaker, stated in the news release. “So, if you book it, you’ve got it. No waiting minutes or hours as you wait to hear back from the property owner. You can now go ahead and book flight, car or tour packages at the same time of your ALR, all on the same site, and without hesitation.” NextTrip is powered by the Monaker Booking Engine (MBE), a cloud-based technology platform that allows for custom integration into virtually any existing booking platform. Monaker aims to leverage this advanced technology to capitalize on the forecast growth of the ALR industry, which is on pace to top $194 billion in 2021, according to Technavio.

To view the full press release, visit http://dtn.fm/jj1Qb

About Monaker

Monaker Group is a technology-driven travel company focused on delivering innovation to alternative lodging rentals (ALR) market. The Monaker Booking Engine (MBE) delivers instant booking of more than 1.2 million vacation rental homes, villas, chalets, apartments, condos and castles. MBE offers travel distributors and agencies an industry-first: a customizable instant booking platform for ALR. Monaker’s NextTrip.com B2C website, also powered by MBE, is the first to offer significant instantly-bookable ALR products along with mainstream travel products and services all on a single site. NextTrip also features rich content, imagery and high-quality video to enhance a traveler’s booking experience and assist in the search, decision and buying process for both individuals and groups. For more information, visit www.monakergroup.com or www.nexttrip.com.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Wednesday, May 24, 2017

India Globalization Capital, Inc. (NYSE: IGC) Taps Dr. Craig Cheifetz as Advisor for Clinical Trials of Cannabis-Based Combination Therapies

India Globalization Capital, Inc. (NYSE MKT: IGC) has named Craig Cheifetz, M.D., as an advisor to aid the company in its clinical trials in microbiology, immunology, neuroscience, and biotechnology. IGC is engaged in the development of cannabis-based therapies, which treat pain, terminal neurological and oncological diagnosis, PTSD, seizures, and other life altering issues. The company, based in Bethesda, Maryland, has a portfolio of patent filings for its phytocannabinoid-based treatments.

In a news release, Ram Mukunda, CEO of IGC, welcomed Cheifetz to the company’s advisory team, noting that he looks forward to Chiefetz’s contributions as IGC develops unique cannabis combination therapies.

Cheifetz is the Medical Director of Inova VIP 360, Northern Virginia’s Concierge Medicine Program. He is also Regional Dean at Virginia Commonwealth University Inova Fairfax Campus.

He received his M.D. from the State University of New York at Buffalo and also attended Georgetown University, where he trained in internal medicine. He was National GRMC Chairman from 2011 to 2013.

“We remain committed to accelerating our initiatives and building robust a portfolio of compounds to address large market conditions,” Mukunda noted in the release.

The company anticipates clinical trials in 2017 for several indications, including pain, a huge market. IGC has already filed for six patents in areas such as eating disorders and epilepsy, in addition to pain. It is working on several more filings for indications including depression, Alzheimer’s and Parkinson’s disease. Its lead candidate is IGC-501, and it has filed patents for the candidate in the United States, Canada and Europe.

For more information, visit the company’s website at www.IGCinc.us

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Conflicts of Interest and the Public Trust

Umpires and referees are hired to impartially officiate their respective games, enforce the rules and ensure fair play. The credence of these officials builds public trust and protects the integrity of the games. Everyone complains that the ump or the ref got the call wrong, but seldom, if ever, does anyone suspect a conflict of interest or believe these officials received payments from players, managers or owners of the teams. If these officials weren’t trustworthy, it would shake the confidence and probity of sports to its core. It would demoralize fans and destroy the games. Billions would be lost by everyone involved with sports. It’s imperative for the very life of the games that these officials maintain honesty and integrity and avoid even the appearance of conflicts of interest. Appearances matter.

If appearances do matter, why then are officials nominated and confirmed to officiate a $23 trillion game? Jay Clayton, a longtime partner at the law firm Sullivan & Cromwell, is the latest nominee to lead the Securities and Exchange Commission. Clayton follows many other SEC heads with multiple intertwined conflicts of interest that bring impartiality into question in regulating Wall Street. Clayton has represented big banks like Goldman Sachs and Barclays as well as prominent hedge funds, corporate executives and numerous companies facing intense government scrutiny. Clayton’s numerous conflicts of interest, intertwined investments and problematic clients were recently chronicled in the New York Times article, Trump’s S.E.C. Nominee Disclosure Offers Rare Glimpse of Clients and Conflicts (http://dtn.fm/t1eD7).

There is no doubt that Clayton is highly experienced and possesses an expansive understanding of market machinations. His knowledge and experience are necessary to rise to the task of running a complex government agency that regulates a complex business that utilizes complex instruments. From inception the SEC has had leadership conflicts of interest.

In 1934, Franklin Roosevelt appointed Joseph Kennedy to head the newly created Securities and Exchange Commission. FDR viewed the SEC as a part of the national recovery from the Great Depression and believed Kennedy was an ideal candidate to rein in all those other Wall Street charlatans. Through experience, Kennedy knew all the fraudulent, questionable backroom ways of lining the pockets of finance’s fat cats, and many believed the fox had been appointed chairman of the hen house. During his two years as SEC chairman, Kennedy stopped many dishonest activities and closed as many loopholes as he could, but his real mission was to make corporations feel good again about doing business. Corporations didn’t trust FDR and the New Deal, but Joe Kennedy was one of them.

Just maybe the game is rigged to promote business. The stated mission of the SEC is to protect investors; maintain fair, orderly, and efficient markets; and facilitate capital formation. The SEC also states that it strives to promote a market environment that is worthy of the public’s trust. With the current and historic appointments made to the SEC and the glaring history of conflicts of interest, it’s obvious that the SEC isn’t promoting an environment worthy of the public’s trust. The SEC is promoting an environment worthy of only the corporations’ trust.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Kootenay Zinc Corp. (CSE: ZNK) (OTCQB: KTNNF) Aims for Strike at Sully Project Amid Global Zinc Shortage

It is a prime time to be in the zinc mining business, and Kootenay Zinc Corp. (CSE: ZNK) (OTCQB: KTNNF) is poised to profit in the midst of a continuing global zinc shortage and simultaneously booming prices.

As recently reported (http://dtn.fm/7RcNS), the price of zinc rose to $1.17 per pound and $2,628 per metric ton as of May 2017, representing a 60 percent increase over the previous year’s prices. This exceeded already propitious predictions that a deeper worldwide shortage would send zinc prices soaring as high as $2,500 per metric ton over the course of 2017 (http://dtn.fm/Mgwq5).

The current imbalance in the global zinc market is partly attributed to the 2016 shutdown of a number of zinc mines in China — the world’s largest producer of zinc, as well as its biggest consumer. Major zinc mines in other parts of the world have been experiencing declining ore supplies, as well, which is further credited as contributing to the shortage.

Seeking to cash in on the current global zinc shortage and price hike and to help meet the growing demand, KTNNF recently reported that it is expanding its active search for zinc at its Sully Project, which is located in British Columbia, Canada, just 18 miles (30 kilometers) from the legendary Sullivan Mine. The company recently reported it has completed three exploration holes at the site and that its project team is extending its survey efforts to the property’s west anomaly, including conducting state-of-the-art gravity mapping.

The Sully Project boasts shared geologic features with the famed Sullivan Mine, and the sedimentary rocks that host the Sullivan Mine are present at Sully, representative of different environments of the same basin. So far, geologic data indicates that the Sully Project shares the same stratigraphic level at which the Sullivan Mine was deposited, and it appears to coincide with the East gravity anomaly at the Sully Project. A subtle lead-zinc soil anomaly could reflect leakage up faults and dispersion through thick till and alluvium from an entirely buried deposit. A Cominco airborne geophysical survey has shown two N-S trending magnetic anomalies underground that are up to almost two miles long (1.86), that are approximately 0.62 miles apart, and that are near-coincident with the gravity anomalies.

So far, drilling efforts at the Sully Project have been a very near miss, meaning a strike may not be far away. Initial surveying at the project indicated that drilling conducted in 2004 only narrowly missed a shallow mass there. Work performed since then indicated the target was deep. The target may have been missed by just 100 meters, according to downhole temperature and magnetic field readings taken in 2014. KTNNF has initiated a drilling program and is targeting this East mass, which has been confirmed and better defined by new gravity data.

For more information, visit the company’s website at www.KootenayZinc.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

BioCorRx, Inc. (BICX) Targeting Alcohol and Opioid Addiction with Innovative Two-Pronged Approach

BioCorRx (OTCQB: BICX) is the owner and creator of an innovative addiction treatment program used by a network of independent treatment centers to improve the lives of their patients struggling with alcohol and opioid addictions. The BioCorRx® Recovery Program leverages an innovative, two-pronged approach that addresses the underlying physical and behavioral issues associated with these addictions. The first half of this approach relies on a highly effective, proprietary implant formulation of the FDA-approved medication naltrexone, for which BioCorRx holds worldwide license rights (excluding Australia and New Zealand). The second half focuses on a modular counseling program coupled with overlapping peer support that is tailored specifically for those afflicted with alcohol and opioid addictions, helping to prepare them both physically and mentally for a life without these often dangerous substances.

America’s opioid epidemic is an increasingly treacherous issue that affects millions of people across the country. Per data from the Centers for Disease Control and Prevention, more than half a million people in the United States died from drug overdose from 2000 to 2015. Of those, more than 60 percent were linked to an opioid. Likewise, deaths from prescription opioids have more than quadrupled since 1999, driven by a nearly identical spike in the amount of prescription opioids sold. The negative implications associated with this addiction include traumatic life events for the addicted and their loved ones, as well as monumental financial expense. A 2010 study conducted by the American Society of Addiction Medicine found that addiction costs an estimated $700 billion annually in the U.S. alone.

Treating this growing problem has proven difficult. In 2011, the Substance Abuse and Mental Health Services Administration reported that 23.5 million persons aged 12 or older, roughly 9.3 percent of the population, needed treatment for an illicit drug or alcohol abuse problem. Of those, only 11.2 percent received the vital treatment at a specialty facility. BioCorRx aims to close this gap by both operating specialty facilities to aid those in need and providing a more thorough treatment program that’s been shown to lower patient drop-out rates, due to reduced cravings, and increase compliance rates, through automatic medication delivery and discreet outpatient treatment options.

In recent months, BioCorRx, through its BioCorRx Pharmaceuticals subsidiary, has looked to continue building on this proven medication through the clinical development of BICX101, a sustained release, injectable naltrexone for the treatment of opioid and alcohol use disorders. In early April, the company announced that three different formulations of the drug candidate showed success in reaching 28 days of sustained release in its preclinical studies, including one with an injection volume of just one milliliter. Following this result, BioCorRx formally requested a pre-IND meeting with the U.S. Food and Drug Administration as it continues to conduct additional studies in order to compile more data points.

In a business update issued earlier this month, Lourdes Felix, CFO, COO and director of BioCorRx, noted the strength of the company’s balance sheet following a March equity financing of $940,000 with accredited investors, as well as an investment of $1.7 million from Alpine Creek Capital Partners. Capital stemming from these transactions is expected to allow BioCorRx to continue executing on its business plan, including completion of “a few rounds of preclinical studies of BICX101” and accelerated sales and marketing activities related to its BioCorRx Recovery Program.

A strong balance sheet isn’t the only aspect of BioCorRx’s growth strategy about which prospective shareholders should be particularly optimistic. On May 16, the company announced its submission of a listing application for the Nasdaq Capital markets. The move comes less than two months after OTC Markets Group (OTCQX: OTCM) welcomed BioCorRx to the OTCQB Venture Market, which it reserves for early-stage and developing companies that are current in their reporting and undergo an annual verification and management certification process. The company will be required to meet a number of Nasdaq listing requirements in order to complete the uplist, but CFO Felix noted that members of BioCorRx’s management team “look forward to the prospect of a NASDAQ listing,” which they anticipate will “enhance BioCorRx’s visibility in the investment community to a larger market and provide for a broader, more diverse base of shareholders.”

Addressing the growing opioid epidemic in the United States, as well as lingering alcohol addiction issues, represents both an urgent call to action and a sizable market opportunity for companies offering proven effective treatment options. BioCorRx, through its innovative non-addictive medication-assisted treatment (MAT) program and promising clinical pipeline, represents an opportunity for the investment community to participate in the resolution of this crisis while capitalizing on the growth prospects of a leading edge health care solutions company.

For more information, visit www.BioCorRx.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – SinglePoint, Inc. (SING) Completes Acquisition of Discount Indoor Garden Supply

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced the completion of its acquisition of Discount Indoor Garden Supply (“DIGS”). Under the terms of the agreement, SinglePoint has acquired a 90 percent stake in DIGS through a stock and cash transaction, further demonstrating the company’s ability to strategically expand its portfolio of investments in established, high-potential cannabis businesses. “This acquisition is an important one for SinglePoint and strengthens our footing in the cannabis industry,” Greg Lambrecht, CEO of SinglePoint, stated in the news release. “The acquisition of DIGS is phenomenal for the company’s books. More importantly though are the people that come along with this. We are investing in people we believe in, people that we know can continue to run and grow their company.” DIGS currently operates both an online store and two store front locations, with plans to open a third in the near future. Both of its stores are strategically located to capitalize on a sizable presence of licensed cannabis growers, which could provide an opportunity for considerable market growth following California’s anticipated 2018 legalization of recreational cannabis use.

To view the full press release, visit http://dtn.fm/56LRe

About SinglePoint, Inc.

SinglePoint, Inc. (SING) has grown from a full-service mobile technology provider to a publicly traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base. Through its subsidiary company SingleSeed the company is providing products and services to the cannabis industry. For more information visit www.SinglePoint.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Kootenay Zinc Corp. (CSE: ZNK) (OTCQB: KTNNF) Featured in Exclusive Audio Interview by NetworkNewsWire

Multifaceted financial news and publishing company NetworkNewsWire (“NNW”) this morning announced the online availability of an exclusive audio interview with mineral exploration and development company Kootenay Zinc Corp. (CSE: ZNK) (OTCQB: KTNNF). In the interview, Stuart (Tookie) Angus, an independent business advisor to the mining industry and member of Kootenay Zinc’s advisory board, offers listeners a run-down of the company’s current operations. Kootenay Zinc is currently focused on the discovery of zinc ore at its mineral property located near the famous Sullivan Mine, which was previously one of the world’s largest zinc/lead/silver deposits, producing over $49 billion worth of metal. “We are about 30 kilometers, or 18 miles, from the mine, with a current drill program underway to try and discover [an extension] for the Sullivan Mine deposit,” Angus noted in the NNW interview. “We have a number of different anomalies that we’re going to test. The truth serum in this business is the drill bit. We’re going to go in there and bravely drill to see if we can find what we hope is there.” The full interview can be head at http://dtn.fm/6q26H.

To view the full press release, visit http://dtn.fm/M9gbD

About Kootenay Zinc Corp.

Kootenay Zinc Corp. is a mineral exploration and development company based in Vancouver, British Columbia that is presently targeting the Sully Property. The company is focused on discovering large-scale sedimentary-exhalative (“SEDEX”) deposits. The Sully Property comprises 1,375 hectares located approximately 30 kilometres east of Kimberley, B.C., and overlies rocks of similar age and origin as those which host the world-class Sullivan deposit, owned by Teck Resources Ltd. Sullivan was discovered in 1892, and is known to be one of the largest SEDEX deposits in the world. Over its 100-year lifetime, Sullivan produced approximately 150 million tonnes of ore, including approximately three hundred million ounces of silver, eight million tonnes of zinc and eight million tonnes of lead. The equivalent level of strata as at Sullivan and that formed on the margin of that same basin are present at the Sully Property. The Company cautions that past results or discoveries on proximate land are not necessarily indicative of the results that may be achieved on the Sully Property. For more information, visit http://www.kootenayzinc.com.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – CD International Enterprises, Inc. (CDII) Enters Full Corporate Offer to Purchase 1.2 Million Tons of Bauxite

CD International Enterprises, Inc. (OTC: CDII), a U.S.-based company that sources industrial commodities and provides business and management corporate consulting services, this morning announced its entry into a full corporate offer with a Dominican Republic-based company for the monthly purchase of 100,000 tons of metallurgical-grade bauxite. Per the terms of the offer, CDII will be required to purchase 100,000 metric tons of bauxite per month for an initial period of 12 months, equating to a total shipment of 1.2 million metric tons. This contract is valued at approximately $37 million based on current FOB prices at Cabo Rojo, Dominican Republic. “We are pleased to enter into this agreement on the heels of signing a separate offer to purchase copper cathodes, valued at approximately $330 million,” Dr. James Wang, chairman and CEO of CDII, stated in the news release. “As part of sourcing a variety of industrial commodities for our clients in China, we are advancing our newly established business model and leveraging our existing connections in China. Upon a successful delivery of bauxite to our clients in China, we believe we will enter a new level of business.”

To view the full press release, visit http://dtn.fm/GqlK3

About CD International Enterprises, Inc.

CD International Enterprises, Inc. (OTC: CDII) is a U.S.-based company that sources industrial commodities and provides business and management corporate consulting services. The breadth of its services allows the Company to be a one-stop shop for international companies looking to take advantage of global market opportunities. For more information about CD International, please visit http://www.cdii.net.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Announces Launch of ‘OptHemp’ Premium Hemp Health Product Line

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX), through wholly-owned subsidiary Chinesehempoil.com Inc., this morning announced plans to launch its own premium hemp health product line, ‘OptHemp’, as well as its first private label product, OptHemp Ultra Premium Hemp Oil. “We believe that the desire for better quality of life in the Chinese community, coupled with fact that the aging population continues to grow, will lead to continued growth in the alternative health sector and increased demand for natural hemp-based health products,” Warren Wang, founder and CEO of CIIX, stated in the news release. “CIIX is confident that its OptHemp product line will lay a solid foundation for the Company’s entrance into the legal hemp industry and the alternative health sector.” When available, the company’s OptHemp products will be sold through www.ChineseHempOil.com, CIIX’s official bi-lingual site. The products will also be available through the company’s first retail store, which is currently under construction in San Gabriel, California, with a tentative opening date set for June.

To view the full press release, visit http://dtn.fm/Uq5oV

About ChineseInvestors.com

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis, and educational related services in Chinese language character sets (traditional and simplified); (b) advertising and public relation related support services; and (c) retail and online sales of hemp-based products and other health related products. For more information visit www.ChineseInvestors.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Tuesday, May 23, 2017

CD International Enterprises (CDII) Expands Reach to 2 Billion+ via the Web

A specialist in the industrial commodities and corporate consulting services sector, CD International Enterprises, Inc. (OTC: CDII) now has access to a global market representing more than two billion prospective customers. The company has been expanding into the cannabidiol (CBD) market and recently launched a wholly-owned subsidiary and online store. Targeting Chinese-speaking communities in the U.S. and around the world, it has also been reaching into the mobile web with the ongoing development of an app to distribute CBD products through mobile devices.

The company launched its online store (http://greencbdproducts.com/cbd) this year, as well as its Green Products Distribution, Inc. subsidiary. These initiatives represent a major component of CD International’s expansion plans. As the online store reaches full functionality, products will be added to the catalog, where a secure online ordering system will enable customers to purchase the highest quality CBD oil and other products.

A contract with an online marketing firm is expected to help expand the reach of the store and its product line. On the sourcing front, the company is planning several distribution agreements with U.S. firms, in addition to its plans to work with pharmaceutical and Chinese Medicine retailers in China. Also, a recent agreement signed with GWR Distributors now means access to wholesale-priced CBD capsules, concentrates, edibles, oils, syrups, and more. This boosts the potential of the online store now in development.

The store will sell over 200 different flavored CBD hemp oils. Vape additives will be available as well. Not psychoactive like tetrahydrocannabinol (THC), CBD has been shown to benefit people with numerous diseases. In clinical studies, it has been found to be effective as a treatment for epilepsy, anxiety, inflammation, neurodegenerative diseases, and autoimmune diseases and to be a powerful antioxidant. The products sourced in the U.S. are produced to high quality standards and are in compliance with ISO 6 clean room standards. The process used yields 99 percent pure CBD isolate.

Reaching $202 million by 2015, the global cannabidiol market represents the fastest growing segment of the marijuana industry, according to a Consilium Global Research report (http://dtn.fm/ZXh2t). It is expected to reach $2.1 billion in consumer sales by 2020. Given the fluidity of U.S. and international law related to medical marijuana, CD International continues to look for new market opportunities amongst the Chinese-speaking population in the United States and abroad. Its global experience with sourcing/selling iron ore, manganese ore, and scrap metals and providing financing and logistics services positions the company to move forward in the CBD market.

“It is an exciting time to source and market CBD-based products. Around the world, the Chinese population remains health conscious, and the health benefits of CBD oils and other products mean these high-quality commodities are in high demand. We’re proud to source our products in the U.S. and have the capacity to distribute them to anywhere in the world,” Dr. James Wang, chairman and CEO of CD International Enterprises, stated in a news release.

Learn more about the Company, its subsidiary, mineral trading and consulting divisions, and growing online CBD products store by going to http://www.cdii.net.

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

ChineseInvestors.com (CIIX) Growing Rapidly in a Rapidly Growing Market

Savvy investors study multiple factors to identify potential stock winners. Stock screeners scan thousands of companies for insights and data to discern uncommon opportunities. The criteria utilized in a stock screening system is obviously influenced by an individual’s investment proclivities such as high yield, value, growth or price momentum, however, most stock screening systems are typically hybrids with blended criteria reflecting individual preferences and incorporating more than one investment style. P/E ratios, near zero beta, increased dividends, revenue growth and market growth are all employed to sift through over 100,000 public companies around the world and the nearly 6,000 U.S. listed companies.

All markets are addicted to growth. Growth is the elixir that drives markets and share prices of individual companies higher, and every stock screening system includes growth measurement variables. Growth is a testament to value creation. Current and future growth are prime indicators of potential future performance of a company’s share price. When looking for growth, it makes sense to look closely at companies that are not only growing rapidly but also growing rapidly in a rapidly growing market. With compound annual growth estimated at nearly 60 percent, the CBD (cannabidiol) industry is arguably the fastest growing market in the world. In fact, just five months ago Forbes called the CBD industry, “The Cannabis Market That Could Grow 700% by 2020” (http://dtn.fm/5vDve). That kind of growth can change a portfolio.

Currently legal in 16 states with more expected to follow, CBD oil is non-psychoactive and considered to have a broad range of medical benefits. Derived from hemp or marijuana plants, CBD has shown varying degrees of efficacy in treating epilepsy, Alzheimer’s disease, cirrhosis, pain, anxiety and stress.

CBD is obviously an explosive market opportunity. However, an even greater market opportunity lies outside the U.S., with over two billion Chinese speaking people. Acceptance and use of CBD oil is a natural fit with holistic Eastern-based medicine and an immense potential revenue generator for ChineseInvestors.com (OTCQB: CIIX). With two billion Chinese speaking people as its target market, ChineseInvestors.com recently executed a first-to-market milestone by creating the world’s only Chinese language, cannabinoid-based, therapeutic health products online store, www.ChineseCBDoil.com.

Historically, this specialized investment services company with 100,000+ users provided real-time market commentary, analysis, and education-related information in the Chinese language, as well as offered consultation, advertising, and public relations services. Now, the 18-year-old company is at the forefront of marketing and selling hemp-based food and beverages and hemp-derived CBD to Chinese-speaking consumers worldwide through its online store.

A recent research report by Consilium Global Research (http://dtn.fm/SA4bH) projects ChineseInvestors.com to grow at a compound annual growth rate (CAGR) of approximately 100% through 2020. Consilium sees CIIX going through immense transformation this year as it pursues a larger stake in the global cannabis market. Before long, ChineseInvestors.com should pop up on multiple stock screeners, as it’s growing rapidly in a rapidly growing market.

For more information, visit the company’s website at www.ChineseInvestors.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – ProBility Media Corp. (PBYA) Enters Letter of Intent to Acquire W Marketing, Inc.

Education technology company ProBility Media Corp. (OTCQB: PBYA) this morning announced its entry into a binding letter of intent to acquire W Marketing, Inc., a profitable, revenue-generating provider of National Electrical Codes (NECs) to the electrical and construction industries. Leveraging W Marketing’s nationwide network of electrical distributors, which includes bookstores, trade/vocational schools, universities, retail chains, specialty retailers and independent hardware stores, ProBility expects this acquisition to strengthen its financial position while allowing it to become one of the nation’s largest wholesalers of National Fire Protection Association (NFPA) electrical codes. “We are pleased to announce this corporate milestone and look forward to demonstrating the short- and near-term value it creates,” Noah Davis, president and chief operating officer of ProBility, stated in the news release. “When the acquisition is complete, ProBility’s buying power will surpass any wholesaler on the market, and open the doors to thousands of electricians who could benefit from our certification courses, continuing education and code books. Additionally, we expect this acquisition of W Marketing will have a positive impact on forward-looking financials.” W Marketing recorded revenues of $2.7 million in fiscal 2017 following the release of the latest update to the NEC.

To view the full press release, visit http://dtn.fm/j8hAJ

About ProBility Media Corp.

ProBility Media Corp. is an EdTech company building the first full-service training and career advancement brand for the skilled trades. Through its divisions Brown Technical Media Corp., Brown Technical Publications Inc., Brown Book Shop, Inc., National Electrical Wholesale Providers, One Exam Prep, LLC, and its partnership with Globalsim Inc., ProBility is executing a disruptive strategy of defragmenting the skilled trades training market place by offering high quality training courses and materials and preparing the workforce for excellence. ProBility services customers from the tradesman to the small business to the enterprise level corporation. For more information, visit http://www.ProBilityMedia.com

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Monday, May 22, 2017

India Globalization Capital, Inc. (NYSE: IGC) Developing Phytocannabinoid-Based Product Pipeline to Treat Two- and Four-Legged Alike

Looking to gain an advantageous foothold in the burgeoning medical marijuana market, India Globalization Capital, Inc. (NYSE MKT: IGC) is developing innovative cannabis-based combination therapies that have application for both humans and animals. The company’s focus is on treating pain, post-traumatic stress disorder (PTSD), chronic and terminal neurological and oncological diagnoses, cachexia, and other life-altering medical conditions.

IGC continues developing a portfolio of patent filings for phytocannabinoid-based treatments and has filed six patents to date. The company currently has three products in pre-clinical trials: IGC-501 for treatment of neuropathic pain in adult humans, IGC-502 for treatment of seizures in animals, and IGC-504 for treatment of cachexia in humans and animals.

Two of IGC’s patent filings, IGC-502 and IGC-505, are for combination therapies to treat seizures in dogs and cats, which represents a remarkably large market. Statistics show that between one percent and over five percent of dogs in the United States have some kind of seizure disorder. Certain dog breeds with hereditary epilepsy may have up to 15-20 percent incidence of seizures.

IGC’s novel therapy uses cannabinoid extracts in combination with other drugs to treat seizures in both dogs and cats, and this therapy has potential for application in humans, as well. The therapy can be administered through a variety of delivery technologies.

Operating on the belief that expanding cannabis legalization will create explosive demand for cannabinoid-based pharmaceutical therapies and related technologies and services, IGC is racing to be at the head of the pack and to be a first mover in the marijuana space by developing novel therapies, filing patent applications, and acquiring technologies from related industries that can cross over to cannabis as soon as permitted by federal law.

The company largely employs an outsourced model and has formed strategic alliances with doctors and scientists with expertise in central and peripheral nervous system disorders, the FDA process, and in pharmaceutical, nutraceutical and veterinarian trials. IGC also continues seeking information exchanges with medical cannabis dispensaries, doctors, research scientists, biotech companies, and medical and business professionals within the cannabinoid space, placing great value on collaborative research that can aid in the commercialization of products and in locating new ways to help patients — both human and animal — benefit from cannabinoids.

For more information, visit the company’s website at www.IGCinc.us

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Thursday, May 18, 2017

India Globalization Capital, Inc. (NYSE: IGC) is Blazing a Trail with its Cannabis Plus Therapies

Slowly but surely cannabis is losing the stigma that has plagued it for close to one hundred years. Even some who frown on its use for recreational purposes are willing to consider that there may be therapeutic benefits in extracts of the cannabis sativa plant and so, increasingly, cannabinoids are being investigated to determine their effectiveness to treat a variety of debilitating medical conditions. Cannabinoid pharma is emerging as an entirely new industry segment in pharmaceuticals, and, as it does so, one innovative research company is blazing a trail in this new market by creating a niche of its own. India Globalization Capital, Inc. (NYSE MKT: IGC) has created its own space in pharmaceuticals. The Bethesda, Maryland-based company is a first mover in “combination therapies” that merge cannabinoids with existing drugs to provide more effective remedies.

IGC is not only a first mover in combination therapies; the company is also a fast mover. To date, IGC has dispatched six provisional patent filings to the U.S. Patent and Trademark Office for the indications of pain, medical refractory epilepsy, seizures, cachexia and eating disorders. Together, the remedies for these conditions present huge market opportunity, and IGC’s current low valuation versus comparable cannabis companies represents an important alert for all investors in this burgeoning industry.

IGC-501 is being developed to combat pain. The pain market represents a significant component of the health care system, with The Journal of Pain reporting in September 2012 that the annual estimated national cost of pain ranges from $560 billion to $635 billion, a figure that exceeds the cost of treating all other priority health conditions. Also, a NetworkNewsWire report on data released by Transparency Market Research estimates the global pain management therapeutics market will have a 3.7 percent CAGR through 2024, to reach $83.0 billion (http://dtn.fm/cMh1z).

Chronic pain takes such an exacting toll on the nation’s health that the American Pain Society has recommended pain be characterized as a fifth ‘vital sign’, along with body temperature, pulse rate, respiratory rate and blood pressure. Pain treatment can save lives. Terminal illnesses are often accompanied by levels of pain so intense and difficult to treat that death seems preferable. In addition, arthritis has been particularly problematic for women, according to the Arthritis Foundation, which reports that since 1999 there has been a 22 percent increase in the number of women who attribute their disability to arthritis.

As awareness of the effects of chronic pain has grown, increasingly powerful drugs such as morphine, codeine, and hydrocodone are being prescribed. However, these opioids are treacherously addictive and their use is often subverted from pain relief, making their way into recreational use. According to the Centers for Disease Control (CDC), 29,000 Americans die every year from opioid-related overdoses. This alarming statistic shows the pressing need for less addictive analgesics like IGC-501.

IGC-503 tackles refractory epilepsy, which affects about 50 million in the U.S. alone. Refractory epilepsy refers to cases of epilepsy that are unresponsive to current medications. Also in the pipeline is IGC-504, intended for those who suffer from cachexia, known as wasting syndrome. About 1.3 million in the U.S. experience cachexia associated with cancer, multiple sclerosis (MS), Parkinson’s, HIV/AIDS and other devastating maladies. In addition, there is IGC-506, designed to combat eating disorders, which are said to affect about 30 million Americans (http://dtn.fm/2j6Pq). Two other patents, IGC-502 and IGC-505, are designed to treat epileptic seizures in dogs and cats.

On the release of its financial results for the third-quarter ended December 31, 2016, CEO Ram Mukunda stated, “In 2017, our goal is to accelerate the development of our cannabis-based therapy portfolio to support key indications such as pain, seizures, cachexia, PTSD, and depression. In tandem, we expect to initiate pre-clinical trials on IGC-501-pain, IGC-502-seizures and IGC-504-cachexia.”

For more information, visit the company’s website at www.IGCinc.us

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Bitcoin Value Soars Despite SEC Rejecting ETF Bid, China Eyeing Trading Regulations

One of the most popular cryptocurrencies on the market, Bitcoin is reaching all-time highs on Asian trading platforms, despite recent challenges. The virtual currency has been rising in value, by 140 percent in 2016 and by roughly 50 percent in the past month alone, trading at over $1,800 on the Chinese market last week (http://dtn.fm/px7Ki). The value has dropped to around $1,700 in the meantime, but the cryptocurrency is expected to continue its growth, even if China is enforcing a series of Bitcoin trading regulations and Japan is considering the same.

One of the biggest challenges the digital currency is facing has to do with getting approval to be tied to an exchange-traded fund in the United States. Earlier this year, the U.S. Securities and Exchange Commission rejected a proposal to create a Bitcoin ETF on account of the lack of clear regulations on the markets where the cryptocurrency is traded (http://dtn.fm/EV7a8). The SEC said the lack of clear regulation on these markets raises concerns about potential manipulative or fraudulent practices in this market.

The application had been submitted by brothers Tyler and Cameron Winklevoss, who have been working on a proposed Bitcoin ETF for four years and have already won New York authorities’ regulatory approval for their virtual currency trading platform, Gemini Exchange. Other companies have also submitted approval request for Bitcoin ETFs to the SEC, and the commission may reach a different decision on those proposals, but approval is unlikely in the near future until more mature markets emerge.

Supporters of the digital currency had hoped that an ETF would help bring Bitcoin into the mainstream and make it available to retail investors via brokerage firms. The regulatory questions surrounding the currency have already deterred many financial institutions from investing significantly into Bitcoin, opting instead to focus on the underlying technology known as blockchain – a revolutionary concept that introduces a new way of processing financial transactions and keeping track of information.

Regulatory concerns over the cryptocurrency also exist on the Asian markets where Bitcoin is traded. China, responsible for almost 90 percent of all Bitcoin exchange trading, is imposing trading fees and controls, aimed at ensuring that bitcoin trading platforms are not becoming money laundering sites. A ban on cryptocurrency exchange withdrawals has also been enforced, and the country is also considering regulations that will require Bitcoin traders to register with their real names. The digital currency is being widely used by Chinese investors as a way of circumventing the country’s strict capital controls and minimizing the risk of significant losses caused by yuan deflation.

Japan, meanwhile, is taking rapid steps toward fully legitimizing the cryptocurrency, by announcing plans to allow interest-paying deposits for Bitcoin. The country has already declared Bitcoin a legal currency, establishing a platform for large corporations and institutional investors to participate in the local digital currency industry.

According to Sandeep Goenka, co-founder of one of India’s leading Bitcoin exchanges Zebpay, news of trading regulations on the two Asian markets and in Russia are partly what is driving the currency’s growth, Cointelegraph reports (http://dtn.fm/XO23d). Goenka believes that the stable growth rate is due to a global increase in awareness toward Bitcoin, as well as a growing demand from institutional investors. Instead of having a dampening effect, trading regulations will only help bring the cryptocurrency into the mainstream, says the Zebpay co-founder. In his opinion, the price of Bitcoin could reach $3,500 by the end of the year.

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Wednesday, May 17, 2017

CD International Enterprises, Inc. (CDII) is Entering a Complex but Rapidly Expanding CBD Market

CD International Enterprises, Inc. (OTC: CDII) is competing in a burgeoning but complex cannabis market estimated to reach $2.1 billion by 2020, according to a new report by Consilium Global Research (http://dtn.fm/PTuL0). Cannabidiol (CBD) is one of the fastest growing segments of the hemp and legal marijuana industries, growing from almost nothing to $202 million by 2015 and growing at a compound annual growth rate (CAGR) of some 80%, per the report. CBD-based products have been shown to relieve pain and inflammation and may treat some neurological disorders.

In that fast-expanding environment, Consilium Global Research found, there are “no brand leaders,” and a lot of entrants into this “nascent market.” The large Chinese population that CDII serves makes for an addressable audience, it said. CDII is active in a variety of industries with a number of worldwide businesses. Among these is a new Green Products Distribution Division and an online store which will target the sale of non-euphoric CBD products at retail to a worldwide Chinese-speaking population, potentially reaching some two billion people globally.

As part of that strategy, CDII has entered into a wholesale distribution agreement with a U.S. manufacturer of CBD-based products. CDII will buy the products at a wholesale price and market them to the Chinese-speaking population.

Consilium Global Research found that the CBD market is quickly expanding, yet is wide open because it has so many entrants. Also, the fluid nature of international and U.S. laws regarding the legality of medical marijuana and related products is ever changing. Currently, the report said, in the 28 states where the product is legal, CBD products are covered by the same medical marijuana protections. It noted that some 16 states have passed CBD-only laws.

The research identified at least six different companies in this burgeoning sector, saying that “it will take a lot to stand out,” and entrants will require funding to remain competitive in this complex but fast-growing market. It added that companies will need to have appropriate resources to address the constantly-changing legality requirements both within the U.S. and abroad.

CDII has a history of activity in a number of global businesses, including the sourcing and sale of minerals and commodities from iron ore and manganese ore to scrap metals and copper for Chinese-based industrial clients. CDII is also a worldwide consultant. CDII has increased its services to also include financing and logistics. Growing its activity in cross-border transactions, CDII has built a number of important international relationships.

For more information, visit the company’s website at www.CDII.net

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Ethema Health Corp. (GRST) Drives Business Success through its Efficiency in Helping Patients Overcome Addiction

Although one of a number of substance abuse recovery and treatment centers in the southeastern coastal area of Florida, the Seastone of Delray – Drug Rehabilitation and Alcohol Treatment Center, owned and run by Ethema Health Corporation (OTCQB: GRST), is already standing out among its peers for the highly efficient individualized treatment options it offers its clients. Located in Delray Beach, which is often referred to as the rehab capital of America, Seastone offers a wide range of treatment programs of varying intensity, depending on each client’s needs. Unlike other centers, Seastone distinguishes itself by the attention paid to the individual client and family, making sure a highly detailed assessment is conducted before a specialized treatment plan is devised.

With a focus on customized treatment plans designed to help clients overcome their substance abuse issues permanently, Ethema Health Corporation’s center provides two forms of outpatient treatment: an intensive outpatient program, and a partial hospitalization program. Both approaches are built around the concepts of cognitive behavioral therapy and peer support, aiming to help clients see themselves and the world more clearly, and realize and accept that they’re facing an addiction issue, ultimately developing their stress management skills and self-esteem for long-term success.

Seastone’s drug and alcohol addiction treatment programs are divided into six stages, being structured for optimum recovery and accommodating any of their treatment plans. The six stages are:

Foundation – where clients get the highest level of direction and support to build a foundation for long-term recovery,
Discovery – where clients are taught to discard unhealthy ideas and habits gained during active addiction,
Creation – the development of sober, effective life skills,
Performance – helping clients gain more responsibility and independence,
Integration – clients continue to achieve more independence and responsibility by reintegrating in society,
Freedom – living full time in the community and dealing with real life issues.

Various treatment options and services are available for substance abuse treatment and recovery, ranging from psychiatric evaluation and drug addiction education to individual and group therapy, Eye Movement Desensitization and Reprocessing treatment, art therapy, yoga or qigong, and more. While it does not provide initial detox services, Seastone does work closely with local detox units to offer clients all the support they need and then transfer them to the facility for long-term treatment. The center’s detox programs are designed to follow and expand on the detoxification process begun in a medical setting, with the purpose of helping clients stay clean and sober for the long term. This stage of the program can begin only after the client is medically stable and free of all withdrawal symptoms.

Ethema Health Corporation’s methods are focused on getting concrete results and complete recovery from addiction, a fact also acknowledged by the Joint Commission on Accreditation of Healthcare Organizations. The worldwide organization has granted Seastone its Gold Seal of Approval®, which speaks to the professionalism and high-quality of services offered. Ethema’s unique efficiencies, together with its outstanding location, are seen as drivers of the company’s long-term operational and financial success

For more information about Ethema Health Corporation and Seastone, visit the substance abuse recovery facility online at www.seastonedrugrehab.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

QualityStocksNewsBreaks – SinglePoint, Inc. (SING) Enters Letter of Intent to Acquire Stake in Discount Indoor Garden Supply

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced its entry into a Letter of Intent with Discount Indoor Garden Supply (“DIGS”). Per the terms of the LOI, SinglePoint will acquire 90 percent of DIGS in a stock and cash transaction. The company anticipates that the acquisition will bring immediate revenues to SinglePoint while positioning it as a leader in online products, retail stores, cannabis consulting and equipment in California. “We are committed to identifying and making investments that will strengthen both parties’ position in the cannabis industry while building SinglePoint’s corporate value,” Greg Lambrecht, CEO of SinglePoint, stated in the news release. “California is a major market opportunity, and we will work to find the right companies, such as DIGS, in which we can invest to gain a stronger foothold in the broader marijuana industry.” In addition to an online store (www.DIGSHydro.com), DIGS currently operates two store front locations strategically located to capitalize on the sustained growth of the California marijuana industry. DIGS has plans to open a third store front location in the near future, and it’s working on a bid to build-out a 15,000 plant operation in Southern California.

To view the full press release, visit http://dtn.fm/PUc0n

About SinglePoint, Inc.

SinglePoint, Inc. (SING) has grown from a full-service mobile technology provider to a publicly traded holding company. Through diversification into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued subsidiaries, thereby providing a rich, diversified holding base. Through its subsidiary company SingleSeed the company is providing products and services to the cannabis industry. For more information visit www.SinglePoint.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Tuesday, May 16, 2017

What the Future of SEC Enforcement Holds

The Dow Jones Industrial Average dropped 25 percent in the span of just four days during the stock market crash of 1929. The ‘29 crash was the worst in U.S. history, destroyed confidence in Wall Street and precipitated the Great Depression. The crash, the resultant financial malaise and shaken public confidence prompted calls for reform, and in 1934, the Securities and Exchange Commission (SEC) was created to restore public trust in capital markets and to oversee the conduct of those markets. Prior to the formation of the SEC, controls on issuing and trading of securities were virtually nonexistent, which allowed stock schemes and frauds to flourish. Rampant unrestricted margin trades and unreported concentrations of controlling interest led to abuses of power and market collapse. In total disregard of any ramifications, businesses, stock issuers and the exchanges essentially colluded and rigged markets to enrich themselves and their associates.

Attempting to restore order amid financial chaos, Congress passed legislation creating the Securities and Exchange Commission. The Securities Act of 1933 required public corporations to register their stock sales and make regular financial disclosures. The Securities Exchange Act of 1934 created the SEC to regulate exchanges, brokers, and over-the-counter markets, and the 1935 Public Utility Holding Company Act banned holding companies that obscured intertwined ownership.

The stated mission of the U.S. Securities and Exchange Commission is to protect investors, maintain fair, orderly, and efficient markets, and facilitate capital formation. Among its many duties, the SEC attempts to prevent market meltdowns by requiring transparency in financial instruments and by regulating stock issuers, brokerage firms and the major stock exchanges. It prohibits certain types of conduct, such as insider trading, and enforces laws that govern the financial industry. When necessary, the SEC enforces securities laws through a variety of means, including fines, referral for criminal prosecution, revocation or suspension of licenses, and injunctions. However, the SEC’s history of fair and equitable enforcement actions has often been called into question.

The Securities and Exchange Commission is a complex independent agency of the federal government which seeks to regulate complex financial instruments and markets. To chair or sit on the commission requires requisite skills and understanding of market complexities. Individuals typically tapped for appointment to the commission have extensive backgrounds, experience and relationships directly or tangentially related to the securities markets.

Herein is the rub… those that seek to regulate the markets and protect the public are cozied up with those that are often the bad actors requiring regulation. Much as during the financial crisis that promulgated the formation of the SEC, the largest market players operate with impunity and reap huge financial rewards. One need look no further than the lack of serious enforcement action (other than fines) after the mortgage shenanigans committed by large banks that led the financial crisis of 2007-2009. The SEC regulators were and still are from the same crowd that they purport to regulate and seem to always have multiple conflicts of interest.

What a conundrum. It requires experience and skill to effectively regulate the markets and its complexities, but those with the skill and experience to effectively regulate come from the very arena that needs oversight and carry luggage crafted from conflicts of interest.

The New York Times explores what the future of enforcement portends http://dtn.fm/40pqH under the latest nominee for chairman of the SEC and the conflicts of interest revealed by his financial disclosure form.

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

ProBility Media Corp. (PBYA) Changing Dreams to Reality

Two recent Wall Street Journal articles reveal that labor pressures are mounting in the construction industry as hiring accelerates across the U.S. economy. The U.S. Labor Department recently reported that nonfarm payrolls rose by a seasonally adjusted 211,000 in April, and the unemployment rate fell to 4.4%, the lowest level in nearly a decade. Contractors across the country report significant shortages of electricians, carpenters, plumbers, and other skilled and semi-skilled laborers as the volume of building projects increases.

The shortage of skilled labor in many markets has forced contractors to boost pay scales, which has been a contributing factor to new home price increases over the past two years. Construction labor costs are currently rising an average of 4% to 5% annually, outpacing inflation, according to Anirban Basu, chief economist of the Associated Builders and Contractors. “The situation is going to get worse,” he said (http://dtn.fm/bm4Uu). It’s estimated that the construction industry presently needs 500,000 more skilled and semi-skilled workers, while another 600,000+ additional workers would be needed should the $1 trillion infrastructure bill proposed by the current administration be passed.

The skilled labor supply shortage isn’t expected to ease soon, as many top construction workers went to work for energy companies during the last building downturn and are now tending to oil rigs and building drilling platforms. ProBility Media Corp. (OTCQB: PBYA) is playing a major role in meeting this fast growing demand for job training and continuing education in the current economy. ProBility is one of the leading online providers of career advancement and training content for tradesmen and technical experts. By building the first full-service training and career advancement brand in the technical fields, the company is changing the landscape of the skilled trades training and certification industry.

ProBility is committed to preparing individuals with training, support, and continued education and teaches the skills needed to land and retain good jobs. The company, through strategic acquisitions, has also become one of the go-to sources for e-learning and training content, exam preparation, testing, certification, continuing education, and career advancement tools for both engineers and tradesmen. The broad collection of the company’s comprehensive educational programs is unparalleled, providing individuals and institutions with the skill sets needed to succeed. ProBility will continue to organically grow revenues from current operations while also strategically acquiring synergistic companies, thereby defragmenting and centralizing the skilled trades training marketplace.

The national unemployment rate for construction workers still remains in double digits, but economists note that figure includes both skilled and unskilled workers and finding a skilled worker not already working is increasingly rare. Finding highly specialized trade workers “is proving very, very difficult,” said James Bolger, director of operations at Colorado Concept Lighting Inc., a high-end electrical contractor that has sought for several months to double its staff of four electricians. “It’s almost like looking for a unicorn or jackalope…” (http://dtn.fm/PfZ0C).

ProBility is changing the search for skilled workers from fantasy to reality and is likely to reward investors along the way.

For more information, visit the company’s website at www.ProBilityMedia.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

SinglePoint (SING) Diversification Strategy Sets Stage for Big Rewards When Cannabis Industry Becomes Bankable

While some investors still view the marijuana market as a new industry, the mammoth potential of the cannabis industry — both in the United States and worldwide — cannot be discounted. While marijuana has not yet been legalized in the U.S. at the federal level, 29 states as well as the District of Columbia have, so far, passed laws or initiatives to legalize or regulate it, and the industry has been growing at an unexpectedly high rate. Some savvy companies are safeguarding against the risk of violating present federal laws by capitalizing on the growth of the cannabis industry in a hands-off way, serving marijuana-related companies without touching the plant themselves. One such company is SinglePoint, Inc. (OTC: SING).

As discussed in a recent article (http://dtn.fm/msS5J), SinglePoint is building an acquisition portfolio of undervalued subsidiaries with a focus on innovative technologies. Within the marijuana industry, the company is pursuing different opportunities to build corporate value and maintain diversification. SingleSeed, SinglePoint’s marijuana vertical, is serving cannabis dispensaries that are currently hampered in their operations due to the present lack of banking options for businesses within the marijuana industry. SingleSeed is engaged in providing mobile payment processing solutions, text message marketing and business tools to marijuana dispensaries, with a long-term goal of building SingleSeed.com into a hub where dispensaries can purchase the products they need to conduct business. It is also planned that SingleSeed will offer consulting services for cannabis businesses that need assistance in getting a foothold and becoming successful in their strategies.

SinglePoint’s own strategy further involves the utilization of marijuana-related technology through its investment in Convectium, which is a successful equipment, branding and packaging solutions provider to the marijuana industry. Convectium has developed the very first cartridge and vape pen oil filling machines created for wholesale distribution to cannabis dispensaries. The 710Shark and 710Seal machines offered by Convectium, currently sold through the EquipCanna.com brand, can fill and package more than 100 cartridges or disposable vape pens in 30 seconds, revolutionizing the inefficient traditional method of hand-filling cartridges. Convectium additionally operates a consumer brand that includes HazeSticks and BlackoutX, with a customer reach that encompasses more than 52 countries.

SinglePoint recently signed a reseller agreement that enables the company to begin onboarding “high risk” merchant accounts, which includes more than 100 types of businesses. Cannabis businesses are currently counted among these high-risk business types, along with enterprises like auctions, gambling, vape pen sales, online gaming and others. Serving SinglePoint’s diversification strategy, this move will enable the company to provide payment solutions to cannabis businesses as soon as the marijuana industry becomes bankable. Offering payment solutions to various verticals in this way enlarges SinglePoint’s target market and paves the way for enormous success in catering to an underserved market.

For more information, visit the company’s website at www.SinglePoint.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

QualityStocksNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Adds Craig Cheifetz, M.D. to Advisory Team

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced that Craig Cheifetz, M.D. has joined the company as an advisor to provide guidance on clinical trials, biotechnology, neuroscience, immunology and microbiology. “I welcome Dr. Cheifetz to the IGC advisory team and look forward to his contributions as we move forward in developing cannabis-based, combination therapies,” Ram Mukunda, CEO of IGC, stated in the news release. “We remain committed to accelerating our initiatives and building a robust portfolio of compounds to address large market conditions.” Cheifetz currently serves as Regional Dean at Virginia Commonwealth University Inova Fairfax Campus and Medical Director of Inova VIP 360, North Virginia’s premier concierge medicine program. He received his M.D. from the State University of New York College at Buffalo and trained in Internal Medicine at Georgetown University.

To view the full press release, visit http://dtn.fm/4kxKk

About IGC

India Globalization Capital is engaged in the development of cannabis-based therapies to treat pain, PTSD, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions. In support of this mission, IGC has assembled a portfolio of patent filings for its phytocannabinoid-based treatments. The company is based in Bethesda, Maryland. For more information visit www.igcinc.us

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Ethema Health Corporation (GRST) Becoming a Leading Addiction Treatment Provider in Florida

Substance abuse, in particular when it comes to prescription drugs, is on the rise across the United States, with an estimated 15 million Americans being addicted to prescription medicine – more than the total number of heroin, cocaine, and hallucinogens users combined. Known as a spring-break destination and a state of heavy drinking, with about 58 percent of people being regular drinkers, Florida also has a serious substance abuse problem, with almost 3,000 drug-induced deaths reported in the state on an annual basis. Organizations such as Ethema Health Corporation (OTCQB: GRST) are working hard to tackle the negative effects of addiction on the local population by offering some of the most innovative and comprehensive substance abuse treatments available across the state.

According to statistics from DrugRehab.com, almost half of people addicted to heroin and opioids in Florida are aged 30 and under, while more than 3,000 of the patients admitted to rehabilitation in 2015 statewide were under 18 years of age (roughly 10.6 percent of the total number of people who sought treatment for their addiction problem). In addition, Florida prescribes up to 10 times more oxycodone than all the other states combined and has one of the highest rates of overdose deaths in the country, according to the Addiction Blog (http://dtn.fm/PF6mi).

The startling figures explain why Florida is also a known center for rehabilitation facilities. Often referred to as the rehab capital of America, Delray Beach is home to multiple addiction centers, including Ethema Health Corporation’s Seastone Drug Rehabilitation and Alcohol Treatment Center. Opened in 2012, the facility’s comprehensive, holistic approach to substance abuse treatment and recovery has quickly positioned it as a leader in a highly competitive market, as well as a center focused on getting long-lasting results and the complete recovery of its clients.

The company’s unique approach revolves around the concept of treating not only the addiction but also any underlying disorders that enabled the substance abuse in the first place. Additionally, the center focuses on providing only highly customized and individualized treatment options, designed to ensure that each and every client gets a treatment plan tailored to their specific needs and problems.

Multiple treatment programs are available at the facility, ranging from drug addiction education and psychiatric evaluation to individual and group therapy, eye movement desensitization and reprocessing, yoga and art therapy, and more. All the treatments are results oriented and focused on the concept of inclusion, which means that throughout their rehabilitation process all clients receive core team support in the form of family or friends. The treatment plans available at the facility are designed to aid clients throughout their entire journey to recovery, from understanding and accepting their addiction problem to developing the necessary skills to live their lives after leaving rehab.

Ethema’s client-focused, non-judgmental approach is making the company a major provider of quality addiction treatment services in Florida. The company’s professionalism has also been acknowledged by the Joint Commission on Accreditation of Healthcare Organizations, which has granted Seastone its Gold Seal of Approval®.

For more information about Ethema Health Corporation and Seastone, visit www.seastonedrugrehab.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

QualityStocksNewsBreaks – CD International Enterprises, Inc. (CDII) Enters Wholesale Distribution Agreement with GWR Distributors, Inc.


CD International Enterprises, Inc. (OTC: CDII), a U.S.-based company that sources industrial commodities and provides business and management corporate consulting services, this morning announced its entry into a wholesale distribution agreement with GWR Distributors, Inc., one of the world’s leading suppliers of cannabidiol-based products derived from hemp. Per the terms of the agreement, CDII will purchase CBD products at a wholesale price from GWR Distributors, including CBD capsules and concentrates, edibles and oils, isolates, syrup and terp and CBD for pets, which it will then market to a global community of more than 1.6 billion Chinese-speaking consumers. “We are very pleased to work with GWR Distributors, one of the world’s leading suppliers of CBD-based products, to bring the best CBD-based products manufactured in the U.S. to our target market,” Dr. James Wang, chairman and CEO of CDII, stated in the news release. “With multiple successful global transactions, a wealth of international relationships, and in-depth knowledge of the innate practices of Chinese commerce and customers, we believe we are well-positioned to take advantage of substantial growth of CBD based products in China for years to come.”

To view the full press release, visit http://dtn.fm/VYD2b

About CD International Enterprises, Inc.

CD International Enterprises, Inc. (OTC: CDII) is a U.S.-based company that sources industrial commodities and provides business and management corporate consulting services. The breadth of its services allows the Company to be a one-stop shop for international companies looking to take advantage of global market opportunities. For more information about CD International, please visit http://www.cdii.net.

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

Monday, May 15, 2017

Financial Choice Bill Likely to Increase Insider Trading Risks for Small Investors

On May 4, 2017, after the House Financial Services Committee approved the Financial CHOICE Act of 2017 (FCA) in a 34-26 vote, Congress moved a step closer to replacing the Dodd-Frank Wall Street Reform and Consumer Protection Act. The bill will now be passed to the full House, proclaiming on the way its objective ‘to create hope and opportunity for investors, consumers and entrepreneurs by… holding Wall Street accountable’. However, many of its proposed changes appear to do the opposite. They hobble the SEC’s enforcement efforts: curtailing prosecutorial approaches and raising the bar for conviction by requiring stricter proof of wrongdoing. Even though other provisions increase the penalties for violations of securities laws, the FCA is likely to expose investors to increased market risk from fraudulent activity, including insider trading.

The scale of insider trading and the profits it promises are enormous. In 2014, for example, Mathew Martoma, a former portfolio manager at SAC Capital Advisors, was convicted for using confidential information to execute trades that yielded him $275 million, dubbed by former U.S. Attorney Preet Bharara, ‘as the “most lucrative” example of insider trading in history’ (http://dtn.fm/gZ5VK). Yet despite such staggering statistics, the FCA undermines the SEC’s ability to go after market manipulators like Martoma by including two provisions.

The first of these, which applies to the ‘standard of proof in administrative proceeding’, raises the bar by requiring the Commission to show ‘clear and convincing evidence’ that securities laws have been broken. This is a much more exacting standard than the ‘preponderance of the evidence’ standard required in federal courts and employed in SEC in-house hearings under existing rubric. Consequently, it is likely the SEC will decrease the number of cases pursued through administrative proceedings as it takes the path of least resistance.

Empowered by Frank-Dodd, in-house or administrative proceedings have proved to be a very effective enforcement tool for the SEC, so much so, that ‘according to a report (on May 9) by Cornerstone Research, the SEC filed 80 percent of its enforcement actions in the first half of fiscal year 2017 as administrative proceedings, not civil suits’, according to Reuters (http://dtn.fm/B1JQu).

The New York Times’ Deal Book explains (http://dtn.fm/RUn0O) this ‘attack on administrative proceedings’ as a ‘reaction to a provision of the Dodd-Frank Act that authorized the S.E.C. to pursue a wider range of penalties in cases filed with its own judges, which is usually a more expeditious procedure.’ The Deal Book story also questions ‘another provision (that) could allow defendants sued by the S.E.C. a means to challenge charges by claiming they had not been informed in advance of the theory of liability being pursued.’ The controversial provision referred to would ‘prohibit the S.E.C. from using “unproven legal theories” to establish a violation’, a clear sign that the FCA intends to keep insider training inside and not extend its penalties to outsiders.

Classic cases of insider trading occur when those who have obtained confidential information by reason of being a fiduciary of a corporation use that information to trade in the corporation’s securities. Such fiduciaries include directors and employees but also those who might temporarily become fiduciaries, such as attorneys, accountants, and consultants. However, in 1997, the Supreme Court, in United States v. O’Hagan, redefined insider trading. By ratifying the ‘misappropriation theory’, it cast a wider net of culpability when non-public information is used to trade securities.

O’Hagan was a partner in a law firm retained by a British company that planned to make a bid for the Pillsbury Company. Although, he was not assigned to work on that deal, O’Hagan learned about it over lunch. He, subsequently, began purchasing shares and options that netted him over $4 million in profits after the acquisition closed. Convicted at first instance of securities violations, the decision was reversed by an appellate court. On appeal by prosecutors, the Supreme Court held that an individual may be found liable for violating rule 10(b)-5, which forbids any fraud or deceit in connection with the purchase or sale of a security, by ‘misappropriating’ confidential information.

Now, any action to close the misappropriations route or make it more difficult for the SEC to take, might amount to declaring open season for insider trading.

At present, the law appears to allow an outsider to trade on confidential information, if the insider divulged the confidential information to the outsider because of friendship rather than for pecuniary gain, particularly if the outsider gave no undertaking that the information would not be used to trade. Indeed, in defending himself from ongoing SEC action, hedge fund billionaire Leon Cooperman is arguing ‘that even if he did get inside information, he did not agree to refuse to trade on it until after he’d already received it—and that therefore, the agreement was moot, from a legal standpoint’, according to Fortune magazine (http://dtn.fm/q2rA5). Cooperman, CEO of Omega Advisors, has been accused of making dozens of trades in Atlas Pipeline Partners securities in 2010, netting profits of $4 million, after learning from a company insider that the troubled oil and gas company was on the verge of a merger deal.

None of this bodes well for the financial markets. If Congress pursues its agenda of hamstringing the SEC, who will protect small investors?

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net